Search Results - "Morla, Shravan"
-
1
Glycosaminoglycans and Glycosaminoglycan Mimetics in Cancer and Inflammation
Published in International journal of molecular sciences (22-04-2019)“…Glycosaminoglycans (GAGs) are a class of biomolecules expressed virtually on all mammalian cells and usually covalently attached to proteins, forming…”
Get full text
Journal Article -
2
A Unique Nonsaccharide Mimetic of Heparin Hexasaccharide Inhibits Colon Cancer Stem Cells via p38 MAP Kinase Activation
Published in Molecular cancer therapeutics (01-01-2019)“…Targeting of cancer stem cells (CSC) is expected to be a paradigm-shifting approach for the treatment of cancers. Cell surface proteoglycans bearing sulfated…”
Get full text
Journal Article -
3
Discovery of Sulfated Small Molecule Inhibitors of Matrix Metalloproteinase-8
Published in Biomolecules (Basel, Switzerland) (09-08-2020)“…Elevated matrix metalloproteinase-8 (MMP-8) activity contributes to the etiology of many diseases, including atherosclerosis, pulmonary fibrosis, and sepsis…”
Get full text
Journal Article -
4
Harnessing Twitter to empower scientific engagement and communication: The ISTH 2020 virtual congress experience
Published in Research and practice in thrombosis and haemostasis (01-02-2021)“…As a result of the coronavirus disease 2019 pandemic, the International Society on Thrombosis and Haemostasis (ISTH), like many societies around the world,…”
Get full text
Journal Article -
5
Novel blood coagulation molecules: Skeletal muscle myosin and cardiac myosin
Published in Journal of thrombosis and haemostasis (01-01-2021)“…Essentials Striated muscle myosins can promote prothrombin activation by FXa or FVa inactivation by APC. Cardiac myosin and skeletal muscle myosin are…”
Get full text
Journal Article -
6
Procoagulant Activity of Skeletal Muscle Myosin Is Not Caused By Contaminating Phosphatidylserine-Vesicles
Published in Blood (05-11-2020)“…Skeletal muscle myosin (SkM) can bind factor (F)Xa and FVa, thereby providing a surface that promotes thrombin generation by the prothrombinase complex…”
Get full text
Journal Article -
7
Skeletal muscle myosin and cardiac myosin attenuate heparin's antithrombin‐dependent anticoagulant activity
Published in Journal of thrombosis and haemostasis (01-02-2021)“…Background Heparin enhances the ability of the plasma protease inhibitor, antithrombin, to neutralize coagulation factor Xa and thrombin. Skeletal muscle…”
Get full text
Journal Article -
8
-
9
Skeletal Muscle Myosin Is Procoagulant By Binding Factor XI Via Its A3 Domain and Enhancing Factor XI Activation By Thrombin
Published in Blood (23-11-2021)“…Blood coagulation mechanisms play key roles in health and disease. Pilot studies using selected human plasmas showed the potential associations of plasma…”
Get full text
Journal Article -
10
Identification of 2‑Sulfonyl/Sulfonamide Pyrimidines as Covalent Inhibitors of WRN Using a Multiplexed High-Throughput Screening Assay
Published in Biochemistry (Easton) (18-07-2023)“…Werner syndrome protein (WRN) is a multifunctional enzyme with helicase, ATPase, and exonuclease activities that are necessary for numerous DNA-related…”
Get full text
Journal Article -
11
Skeletal muscle myosin promotes coagulation by binding factor XI via its A3 domain and enhancing thrombin-induced factor XI activation
Published in The Journal of biological chemistry (01-02-2022)“…Skeletal muscle myosin (SkM) has been shown to possess procoagulant activity; however, the mechanisms of this coagulation-enhancing activity involving plasma…”
Get full text
Journal Article -
12
Selective Inhibition of a Panel of Cancer Stem Cell Lines by Novel Glycosaminoglycan Mimetics
Published in The FASEB journal (01-04-2019)“…Purpose To characterize the anti‐cancer stem cell (CSC) properties of non‐saccharide glycosaminoglycan mimetics (NSGMs) and their lipid‐modified analogs in a…”
Get full text
Journal Article -
13
Procoagulant activities of skeletal muscle and cardiac myosins require both myosin protein and myosin-associated anionic phospholipids
Published in Blood (01-04-2021)Get full text
Journal Article -
14
Designing Synthetic, Sulfated Glycosaminoglycan Mimetics That Are Orally Bioavailable and Exhibiting In Vivo Anticancer Activity
Published in Journal of medicinal chemistry (26-01-2023)“…Sulfated glycosaminoglycans (GAGs), or synthetic mimetics thereof, are not favorably viewed as orally bioavailable drugs owing to their high number of anionic…”
Get full text
Journal Article -
15
Abstract 6353: Cholesterol modification enhances potency and pharmacokinetic properties of a selective cancer stem cell targeting agent
Published in Cancer research (Chicago, Ill.) (15-08-2020)“…Abstract Increasing evidence supports the concept that tumor-initiating cancer stem cells (CSCs) are responsible for the relapse and reconstitution of formerly…”
Get full text
Journal Article -
16
On the Process of Discovering Leads That Target the Heparin-Binding Site of Neutrophil Elastase in the Sputum of Cystic Fibrosis Patients
Published in Journal of medicinal chemistry (13-06-2019)“…Cystic fibrosis (CF) is a disease of dysregulated salt and fluid homeostasis that results in the massive accumulation of neutrophil elastase, resulting in lung…”
Get full text
Journal Article -
17
A small, synthetic glycosaminoglycan mimetic as an inhibitor of human heparanase
Published in The FASEB journal (01-04-2019)“…Human heparanase (HPSE) is an endo‐b‐D‐glucuronidase that cleaves glycosaminoglycan (GAG) chains of heparan sulfate proteoglycans (HSPGs) present on cell…”
Get full text
Journal Article -
18
Lipophilic Modification of an Anti‐Cancer Stem Cell Agent Improves Pharmacokinetic and Anti‐Cancer Properties
Published in The FASEB journal (01-04-2019)“…Current anti‐cancer agents target bulk tumor cells but do not eradicate the rare, quiescent, cancer stem cells (CSCs). CSCs are being increasingly recognized…”
Get full text
Journal Article -
19
Polymeric fluorescent heparin as one-step FRET substrate of human heparanase
Published in Carbohydrate polymers (01-02-2019)“…•Development of polymeric heparin as a FRET substrate of heparanase.•The FRET substrate enables rapid, one-step screening of heparanase inhibitors.•The FRET…”
Get full text
Journal Article -
20
A synthetic heparin mimetic that allosterically inhibits factor XIa and reduces thrombosis in vivo without enhanced risk of bleeding
Published in Journal of thrombosis and haemostasis (01-12-2019)“…Background Human factor XIa (FXIa) is an actively pursued target for development of safer anticoagulants. Our long‐standing hypothesis has been that…”
Get full text
Journal Article